Literature DB >> 3585287

A sequential study of viral DNA in serum in experimental transmission of duck hepatitis B virus.

R Fukuda, S Fukumoto, Y Shimada.   

Abstract

To understand the relationship among the time of infection, infection patterns, and liver diseases, experimental transmission of duck hepatitis B virus (DHBV) utilizing 165 Japanese white domestic ducklings was performed. Twenty to 25 ducklings were each inoculated with DHBV-positive serum intravenously at day one, 3, 5, 7, 10, and 14 posthatch and were sacrificed during the 1st, 2nd, 3rd, and 4th (and 24th in those inoculated on day one and day 3 posthatch) week after inoculation to obtain sera and the liver. The sera served for the measurement of DHBV DNA by spot hybridization test and DNA polymerase activity, and the liver was subjected to morphological examination including immunostaining for DHBV. The ducklings inoculated with DHBV on 1 day and 3 days posthatch always revealed persistent viremia, whereas those on and after 5 days posthatch showed persistent or transient viremia. The hepatitis activity in the liver was seen in ducklings inoculated with DHBV on and after 3 days posthatch and was very weak consistent with the diagnosis of mild acute hepatitis of humans. The serum transaminase activity was not significantly elevated at the time of occurrence of histological hepatitis activity. Since host immune mechanism establish at 3 to 5 days posthatch in birds, the host immune response seemed to determine whether DHBV infection was persistent or transient and the occurrence of hepatitis activity as seen in human hepatitis B virus (HBV) infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3585287     DOI: 10.1002/jmv.1890210403

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues.

Authors:  B E Korba; P J Cote; F V Wells; B Baldwin; H Popper; R H Purcell; B C Tennant; J L Gerin
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

2.  Expression rate of cytokine mRNA in the liver of chronic hepatitis C: comparison with chronic hepatitis B.

Authors:  R Fukuda; S Satoh; X T Nguyen; Y Uchida; N Kohge; S Akagi; S Ikeda; M Watanabe; S Fukumoto
Journal:  J Gastroenterol       Date:  1995-02       Impact factor: 7.527

3.  The sequential change of serum 2',5' oligoadenylate synthetase in different infectious patterns of duck hepatitis B virus in ducks in experimental transmission.

Authors:  S Akagi; R Fukuda; Y Shimada
Journal:  Gastroenterol Jpn       Date:  1992-06

4.  Inflammation of the liver causes mutations in duck hepatitis B virus genome.

Authors:  R Fukuda; N Kohge; S Akagi; N T Xuan; A Tokuda; S Fukumoto
Journal:  Gastroenterol Jpn       Date:  1993-04

5.  Effects of acyclovir and vidarabin 5'-monophosphate on anti-duck hepatitis B virus in an in vitro culture system.

Authors:  K Motegi
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

6.  Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques.

Authors:  Benjamin J Burwitz; Jochen M Wettengel; Martin A Mück-Häusl; Marc Ringelhan; Chunkyu Ko; Marvin M Festag; Katherine B Hammond; Mina Northrup; Benjamin N Bimber; Thomas Jacob; Jason S Reed; Reed Norris; Byung Park; Sven Moller-Tank; Knud Esser; Justin M Greene; Helen L Wu; Shaheed Abdulhaqq; Gabriela Webb; William F Sutton; Alex Klug; Tonya Swanson; Alfred W Legasse; Tania Q Vu; Aravind Asokan; Nancy L Haigwood; Ulrike Protzer; Jonah B Sacha
Journal:  Nat Commun       Date:  2017-12-15       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.